USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/4363
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCerlat, Sofia
dc.date.accessioned2019-06-25T15:13:57Z-
dc.date.available2019-06-25T15:13:57Z-
dc.date.issued2011
dc.identifier.citationCERLAT, Sofia. Farmaco - şi fitoterapia modernă a migrenei. In: Anale ştiinţifice ale USMF “Nicolae Testemiţanu”. Ed. a 12-a. Chişinau: СEP Medicina, 2011, vol. 1: Probleme medico-biologice şi farmaceutice, pp. 355-360.en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/4363-
dc.descriptionConducător ştiinţific, Veaceslav Gonciar, d.h.m., profesor universitar Catedra Farmacologie şi Farmacie clinică, USMF „Nicolae Testemiţanu"en_US
dc.description.abstractIt was made an analysis of contemporary therapy of migraine, a review of preclinical and clinical data of a new migraine management, presenting clinical trial results based on the information from the observation files of patients with chronic migraine. Migraine treatment has evaluated in the last decade, several new approaches to the treatment of migraine have been substantially advanced, including selective 5-hydroxytryptamine 1B/1D (5-HT1B/1D) receptor agonists, the launch of sumatriptan was later followed by the appearance of a series of new compounds serotonin agonists, second generation (5-TH B/D): almotriptan, eletriptan, frovatriptan, naratriptan, zolmitriptan and a new class of drugs 5-HT(1F) receptor agonists, called third generation, such as LY344864. A fost efectuată o analiză a terapiei contemporane a migrenei, revizuirea datelor preclinice şi clinice în managementul migrenei, cu prezentarea rezultatelor studiului clinic în baza fişelor de observaţie a pacienţilor cu migrenă cronică. Tratamentul migrenei a evoluat în ultimul deceniu, au fost avansate substanţial multe abordări noi antimigrenoase, inclusiv introducerea agoniştilor selectivi ai receptorilor 5-hidroxitriptamină 1B/1D (5-HT1B/1D). Lansarea sumatriptanului a fost ulterior urmată de apariţia unei serii de noi compuşi agonişti serotoninergici, de generaţia doua (5-TH B/D): almotriptan, eletriptan, frovatriptan, naratriptan, zolmitriptan şi o nouă clasă de medicamente, de generaţia a treia, agoniştii receptorilor 5-HT (1F), cum ar fi LY344864.en_US
dc.language.isootheren_US
dc.publisherCEP Medicinaen_US
dc.subject.meshMigraine Disordersen_US
dc.subject.meshMigraine Disorders - drug therapyen_US
dc.subject.meshSerotonin Receptor Agonists - therapeutic useen_US
dc.subject.meshSerotonin Receptor Agonists - pharmacologyen_US
dc.subject.meshReceptors, Serotonin - drug effectsen_US
dc.titleFarmaco - şi fitoterapia modernă a migreneien_US
dc.title.alternativeModern pharmaco- and phytotherapy of the migraineen_US
dc.typeArticleen_US
Appears in Collections:Farmacologie și farmacologie clinică

Files in This Item:
File Description SizeFormat 
FARMACO_SI_FITOTERAPIA_MODERNA_A_MIGRENEI.pdf168.09 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback